Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
REEP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GMFG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MUS81 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMZ2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FDFT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POU2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
N4BP2L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WWC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPAGT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGFBR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TKFC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on